Cerebellar Anaplastic Astrocytoma in an Adult with Neurofibromatosis Type 1: Case Report and Review of Literature

Abstract

Background Low-grade gliomas (e.g., pilocytic astrocytomas) are frequently found in patients with neurofibromatosis type 1 (NF1). Whereas most of those lesions are located supratentorially, cerebellar manifestations are described in < 1%. Malignant variants like glioblastoma and anaplastic astrocytoma (AA) are only rarely observed in NF1 patients. Thus, cerebellar AA is very infrequent and has not yet been described in an adult NF1 patient.

Clinical Presentation We present the case of a 54-year-old male patient with von Recklinghausen disease who had a diffuse contrast-enhancing cerebellar mass that was resected guided by aminolevulinic acid (ALA)-fluorescence. Histopathological analyses revealed an AA with lack of pilocytic features or O6-methylguanine-DNA methyltransferase (MGMT) promoter hypermethylation. Due to the proximity of the tumor to the brainstem, adjuvant temozolomide chemotherapy was administered rather than first-line radiotherapy. Although the patient recovered quickly after the operation and tumor progression was ruled out in follow-up magnetic resonance imaging (MRI), the patient strongly deteriorated during a 16-month follow-up, and MRI revealed severe leukoencephalopathy. Extensive electrophysiological and radiological examination revealed a neurodegenerative disease of unknown etiology. Finally, the patient's condition improved receiving levodopa.

Conclusions A literature search yielded only one previously published case of an AA in a 9-year-old girl with NF1. Tumor control after resection was achieved in both patients; however, the patient in the mentioned report received radiation instead of temozolomide. In spite of different adjuvant therapies, tumor control for at least 16 months was achieved in both published cases. Thus, even though the role of adjuvant treatment options remains to be further elucidated, surgery is the appropriate therapy in these uncommon tumors providing mass reduction and histological diagnosis as well as tumor control.

Keywords

anaplastic astrocytoma - cerebellum - neurofibromatosis - Recklinghausen disease

• References

• 1 Greenberg MS. Neurocutaneous disorders. In: Greenberg MS. Handbook of Neurosurgery. 7th ed. New York: Thieme Medical Publishers; 2010: 722-724
• 2 Guillamo JS, Créange A, Kalifa C , et al; Réseau NF France. Prognostic factors of CNS tumours in Neurofibromatosis 1 (NF1): a retrospective study of 104 patients. Brain 2003; 126 (Pt 1) 152-160
• 3 Rosenfeld A, Listernick R, Charrow J, Goldman S. Neurofibromatosis type 1 and high-grade tumors of the central nervous system. Childs Nerv Syst 2010; 26 (5) 663-667
• 4 von Deimling A, Perry A. Neurofibromatosis type 1. In: Louis DN, Ohgaki H, Wiestler OD, , et al, eds. WHO Classification of Tumors of the Central Nervous System. 4th ed. Lyon: International Agency on Cancer Research; 2007: 206-209
• 5 Pascual-Castroviejo I, Pascual-Pascual SI, Viaño J , et al. Posterior fossa tumors in children with neurofibromatosis type 1 (NF1). Childs Nerv Syst 2010; 26 (11) 1599-1603
• 6 Tsuda K, Ishikawa E, Saito A , et al. Primary cerebellar pilocytic astrocytoma with anaplastic features in a patient with neurofibromatosis type 1 - case report -. Neurol Med Chir (Tokyo) 2011; 51 (4) 315-318
• 7 Vinchon M, Soto-Ares G, Ruchoux MM, Dhellemmes P. Cerebellar gliomas in children with NF1: pathology and surgery. Childs Nerv Syst 2000; 16 (7) 417-420
• 8 Brokinkel B, Fischer BR, Peetz-Dienhart S , et al. MGMT promoter methylation status in anaplastic meningiomas. J Neurooncol 2010; 100 (3) 489-490
• 9 Ilgren EB, Kinnier-Wilson LM, Stiller CA. Gliomas in neurofibromatosis: a series of 89 cases with evidence for enhanced malignancy in associated cerebellar astrocytomas. Pathol Annu 1985; 20 (Pt 1) 331-358